REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (RVPH)
CUSIP: 76152G100
Q3 2023 13F Holders as of 30 Sep 2023
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 12,805,677
- Total 13F shares
- 2,663,385
- Share change
- -98,331
- Total reported value
- $13,004,016
- Put/Call ratio
- 162%
- Price per share
- $4.88
- Number of holders
- 24
- Value change
- -$556,556
- Number of buys
- 11
- Number of sells
- 12
Quarterly Holders Quick Answers
What is CUSIP 76152G100?
CUSIP 76152G100 identifies RVPH - REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 76152G100:
Top shareholders of RVPH - REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
6.4%
|
824,000
|
$4,828,640 | — | 30 Jun 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.8%
|
615,932
|
$3,609,361 | — | 30 Jun 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
3.6%
|
459,676
|
$2,693,701 | — | 30 Jun 2023 | |
| COLONY GROUP LLC |
13F
|
Company |
1.2%
|
155,000
|
$908,000 | — | 30 Jun 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
150,949
|
$884,561 | — | 30 Jun 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.7%
|
90,006
|
$527,435 | — | 30 Jun 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.65%
|
83,221
|
$487,675 | — | 30 Jun 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.35%
|
44,400
|
$260,184 | — | 30 Jun 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.28%
|
35,300
|
$207,000 | — | 30 Jun 2023 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.24%
|
30,452
|
$178,000 | — | 30 Jun 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.21%
|
27,115
|
$158,894 | — | 30 Jun 2023 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.15%
|
18,911
|
$111,000 | — | 30 Jun 2023 | |
| Virtu Financial LLC |
13F
|
Company |
0.14%
|
18,448
|
$108,000 | — | 30 Jun 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.13%
|
16,327
|
$95,676 | — | 30 Jun 2023 | |
| WOLVERINE ASSET MANAGEMENT LLC |
13F
|
Company |
0.11%
|
14,501
|
$84,975 | — | 30 Jun 2023 | |
| EMC Capital Management |
13F
|
Company |
0.07%
|
8,887
|
$83,000 | — | 30 Jun 2023 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.1%
|
13,382
|
$78,000 | — | 30 Jun 2023 | |
| Belvedere Trading LLC |
13F
|
Company |
0.09%
|
12,109
|
$70,959 | — | 30 Jun 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.09%
|
11,109
|
$65,099 | — | 30 Jun 2023 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0.07%
|
9,299
|
$54,492 | — | 30 Jun 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.04%
|
5,115
|
$29,974 | — | 30 Jun 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
757
|
$4,436 | — | 30 Jun 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
192
|
$1,125 | — | 30 Jun 2023 | |
| VEDANTA PARTNERS, LLC |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
1,127,207
mixed-class rows
|
— | — | 08 Sep 2022 |
Institutional Holders of REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (RVPH) as of Q3 2023
As of 30 Sep 2023,
REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (RVPH) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,663,385 shares.
The largest 10 holders included
VANGUARD GROUP INC, ARMISTICE CAPITAL, LLC, MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, COLONY GROUP LLC, GROUP ONE TRADING, L.P., EMC Capital Management, BlackRock Inc., GSA CAPITAL PARTNERS LLP, and Belvedere Trading LLC.
This page lists
24
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2023 vs Q2 2023 Across Filers
Q2 2023 holders
22
Q3 2023 holders
24
Holder diff
2
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 Value $ | Q3 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.